ST
STE
Quarter ended Mar 31, 2024 · FY2024 FY

STERIS (STE) Revenue — Quarter Ended Mar 31, 2024

Revenue for the quarter increased. The growth was reflected in both sequential and year-over-year comparisons.

Key takeaway

Quarter ended Mar 31, 2024 · FY2024 FY

Revenue for the quarter increased. The growth was reflected in both sequential and year-over-year comparisons.

Financial snapshot

Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.

Quarter revenue

$1.4B

Revenue reported for this quarter.

Quarter-over-quarter

+9.4%

Change from the immediately preceding quarter.

Year-over-year

+10.8%

Change from the comparable year-ago quarter.

Trailing four quarters

$5.1B

Sum of the latest four reported quarters.

Quarterly revenue trend

The latest four reported quarters with year-over-year comparisons.

Period endedRevenueYear-over-year change
Jun 30, 2023$1.2B+12.5%
Sep 30, 2023$1.2B-5.1%
Dec 31, 2023$1.3B+6.7%
Mar 31, 2024$1.4B+10.8%

Revenue performance

The reported revenue direction was upward. The quarter's top line exceeded that of the prior period.

Quarterly comparison

Compared to the immediately preceding quarter, revenue rose. Compared to the same quarter one year earlier, revenue also increased.

What to watch

The year-over-year growth rate was higher than that of the prior quarter, indicating a possible acceleration.

STERIS (STE) Revenue — Quarter Ended Mar 31, 2024